View of Disparity in access to anti-HER2 therapies in neoadjuvant chemotherapy: a prognostic analysis based on real world data between public and private systems in Brazil

Return to Article Details Disparity in access to anti-HER2 therapies in neoadjuvant chemotherapy: a prognostic analysis based on real world data between public and private systems in Brazil Download Download PDF